Approval · Notice of Compliance 33010 · 2024
PENTHROX: Notice of Compliance 33010
Issued April 5, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33010
- Date
- April 5, 2024
- Company
- Endo Ventures Ltd
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph (PM), updates to the outer labels and PM migration to master template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PENTHROX | Not yet assigned | — |
Medicinal ingredients
- METHOXYFLURANE 99.9 PER